Skip to content

Effect of Gulpha Marma Chikitsa and Yavani Churna in menstrual pain.

An Anatomico-clinical study on comparative effect of Gulpha Marma Chikitsa & Yavani Churna in Primary Dysmenorrhoea (Krichhartava)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053385
Enrollment
90
Registered
2023-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Faculty of Ayurveda IMS Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing to participate in study. 2 Age group between 14 to 45 years. 3 Unmarried and married both patients attending the OPD with chief complain of Primary Dysmenorrhoea with scanty or average amount of menses along with associated symptoms without any organic pathology. 4 patients suffering more than two cycles.

Exclusion criteria

Exclusion criteria: 1 Patients below 14 years and above 45 years. 2 Any abnormalities detected in investigation. 3 Coagulation disorders. 4 Patients suffering from chronic systemic disease like uncontrollable diabetes, uncontrollable hypertension, venereal disease, thyroid dysfunction or any disorders influencing general physical health and ultimately influencing menses. 5 Patients using IUCD and OCPs or injectables contaceptive and others. 6 Patients with any history of allergy or allergy from trial drugs. 7 Patients having Central nervous system disorders like epilepsy, meningitis, migraine or any other psychological disorders. 8 Patients having Respiratory disorders like bronchial asthma, T.B., pleural effusion, bronchitis etc. 9 Patients having any carcinoma.

Design outcomes

Primary

MeasureTime frame
Reduced Intensity and Duration of pain during menstruationTimepoint: Before intervention and Every month after intervention for 4 months

Secondary

MeasureTime frame
Relief in associated sign and symptomsTimepoint: Before intervention and Every month after intervention for 4 months

Countries

India

Contacts

Public ContactDR AMITA SHARMA

Faculty of Ayurveda IMS Banaras Hindu University

hhawasthi10@yahoo.in9415813194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026